Neurogastrx Bags $45M, a New CEO and a HQ Move to the Greater Boston Area Post author:Sam Post published:January 3, 2018 Post category:BioPharma The Series A financing was co-led by 5AM Ventures, OrbiMed Advisors and venBio Partners. Source: BioSpace You Might Also Like Recipharm AB Makes Strategic Appointment In The UK & Ireland May 25, 2017 A Look Inside Takeda's Remarkable R&D Transformation February 26, 2017 Who Might or Might Not Buy Regeneron, And Why January 19, 2017
